US 10597392
Tetrahydropyridopyrazines as modulators of GPR6
granted A61PA61P25/00A61P25/16
Quick answer
US patent 10597392 (Tetrahydropyridopyrazines as modulators of GPR6) held by Takeda Pharmaceutical Company Limited expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/00, A61P25/16, A61P25/18, A61P25/24